The effect of a novel pentadecapeptide BPC 157 on development of tolerance and [PMID: 10707891] Laboratory literature summary: The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of
Melanotan I Originally developed for medical purposes, such as treating rare light-sensitive conditions like erythropoietic protoporphyria (EPP), Melanotan I is approved in some contexts under strict medical supervision (e.g., Scenesse)
6 Targeting ferroptosis for the prevention and treatment of neurodegenerative diseases: strategies and future perspectives Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged as a critical mechanism in the pathogenesis of various neurodegenerative diseases and aging-related disorders (404408)
10.1024/0300-9831/a000021 200
However, a unified perspective reveals both convergent pathophysiological endpoints and paradoxical protective pathways that collectively define the metabolic landscape of DKD (see Figure 4)
BMC Endocrine Disorders , 19 (1).